Krebs Biochemicals Closes Trading Window for Q1 FY27

Krebs Biochemicals & Industries Ltd has announced the closure of its trading window for the quarter ended June 30, 2026. This closure, effective from the close of business hours on June 30, 2026, is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut until 48 hours after the declaration of the unaudited financial results for the first quarter. The specific date for the Board meeting to consider these results will be communicated separately to the stock exchanges.